{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:53Z","timestamp":1791176093661,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.m3930","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T15:38:54Z","timestamp":1603813134000},"page":"m3930","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Non-invasive prenatal testing for aneuploidy screening"],"prefix":"10.1136","author":[{"given":"Rebecca","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwan","family":"Wimalasundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"2020102910000890000_371.oct27_3.m3930.1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20353"},{"key":"2020102910000890000_371.oct27_3.m3930.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.01.032"},{"key":"2020102910000890000_371.oct27_3.m3930.3","first-page":"239","article-title":"Non-invasive prenatal testing in the National Health Service","volume":"176","author":"Spencer","year":"2016","journal-title":"Bulletin of the Royal College of Pathologists"},{"key":"2020102910000890000_371.oct27_3.m3930.4","doi-asserted-by":"publisher","DOI":"10.1002\/uog.12331"},{"key":"2020102910000890000_371.oct27_3.m3930.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.01.009"},{"key":"2020102910000890000_371.oct27_3.m3930.6","unstructured":"Joynson C. Our concerns about non-invasive prenatal testing (NIPT) in the private healthcare sector. Nuffield Council on Bioethics, 2019. https:\/\/nuffieldbioethics.org\/blog\/nipt-private."},{"key":"2020102910000890000_371.oct27_3.m3930.7","unstructured":"Nuffield Council on Bioethics. Non-invasive prenatal testing: ethical issues. 2017. https:\/\/www.nuffieldbioethics.org\/publications\/non-invasive-prenatal-testing."},{"key":"2020102910000890000_371.oct27_3.m3930.8","unstructured":"United Kingdom National Screening Committee. UK NSC non-invasive prenatal testing (NIPT) recommendation. 2016. https:\/\/legacyscreening.phe.org.uk\/downs."},{"key":"2020102910000890000_371.oct27_3.m3930.9","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001406"},{"key":"2020102910000890000_371.oct27_3.m3930.10","unstructured":"Human Genetics Society of Australia, Royal Australian and New Zealand College of Obstetricians and Gynaecologists Joint Committee. Prenatal screening and diagnostic testing for fetal chromosomal and genetic conditions. 2018. https:\/\/ranzcog.edu.au\/RANZCOG_SITE\/media\/RANZCOG-MEDIA\/Women%27s%20Health\/Statement%20and%20guidelines\/Clinical-Obstetrics\/Prenatal-screening_1.pdf?ext=.pdf."},{"key":"2020102910000890000_371.oct27_3.m3930.11","unstructured":"Hill M Chitty L . Noninvasive prenatal screening and diagnosis using cell-free fetal DNA. In: Milunsky A Milunsky J , eds. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 7th ed. John Wiley & Sons, 2016: 453-82."},{"key":"2020102910000890000_371.oct27_3.m3930.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705345"},{"key":"2020102910000890000_371.oct27_3.m3930.13","unstructured":"Antenatal Results and Choices. Questions to ask when you are having NIPT in the private sector. https:\/\/www.arc-uk.org\/tests-explained\/non-invasive-prenatal-testing-nipt\/questions-to-ask-when-having-nipt-in-the-private-sector."},{"key":"2020102910000890000_371.oct27_3.m3930.14","unstructured":"Public Health England . Fetal anomaly screening programme standards 2015-2016. PHE, 2015."},{"key":"2020102910000890000_371.oct27_3.m3930.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010002"},{"key":"2020102910000890000_371.oct27_3.m3930.16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm3020388"},{"key":"2020102910000890000_371.oct27_3.m3930.17","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4804"},{"key":"2020102910000890000_371.oct27_3.m3930.18","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5620"},{"key":"2020102910000890000_371.oct27_3.m3930.19","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20290"},{"key":"2020102910000890000_371.oct27_3.m3930.20","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15006"},{"key":"2020102910000890000_371.oct27_3.m3930.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093559"},{"key":"2020102910000890000_371.oct27_3.m3930.22","unstructured":"Chitty L, Cameron L, Daley R, et al. RAPID non-invasive prenatal testing (NIPT) evaluation study: a report for the UK National Screening Committee. Executive summary. UK NSC, 2015."},{"key":"2020102910000890000_371.oct27_3.m3930.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218166"},{"key":"2020102910000890000_371.oct27_3.m3930.24","first-page":"1","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment","volume":"19","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"key":"2020102910000890000_371.oct27_3.m3930.25","doi-asserted-by":"publisher","DOI":"10.1159\/000491750"},{"key":"2020102910000890000_371.oct27_3.m3930.26","unstructured":"Genomeweb. Swiss health insurance to cover NIPT if first trimester screening indicates high trisomy risk. 2015. https:\/\/www.genomeweb.com\/molecular-diagnostics\/swiss-health-insurance-cover-nipt-if-first-trimester-screening-indicates-high#.XX-7-y3Mzy0."},{"key":"2020102910000890000_371.oct27_3.m3930.27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m3930","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m3930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:19:06Z","timestamp":1696961946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m3930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":27,"alternative-id":["10.1136\/bmj.m3930"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m3930","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}